Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Higher education (OR = 1.23, SE = 0.05, 95% CI = [1.10, 1.36], p < 0.001), female sex (OR = 1.30, SE = 0.09, 95% CI = [1.10, 1.55], p = 0.003), and lower age (OR = 0.67, SE = 0.04, 95% CI = [0.61, 0.73], p < 0.001) were associated with increased odds of SuperAger status. Absence of hypertension (OR = 0.76, SE = 0.08, 95% CI = [0.64, 0.89], p < 0.001), lower depressive symptoms (OR = 0.99, SE = 0.01, 95% CI = [0.98, 1.00], p = 0.05), higher fruit and vegetable intake (OR = 1.08, SE = 0.03, 95% CI = [1.02, 1.15], p = 0.01), and greater social activity engagement (OR = 1.03, SE = 0.01, 95% CI = [1.01, 1.06], p = 0.02) were also associated with higher odds. These findings suggest hypertension, depressive symptoms, diet, and social engagement show promising but modest associations with SuperAger status, however, they do not fully explain exceptional cognitive ageing. We aimed to investigate whether established dementia risk factors are associated with SuperAger status in older age. We found that the absence of hypertension, lower depression scores, greater fruit and vegetable intake, and higher social engagement were associated with an increased likelihood of being a SuperAger, although these associations were modest. Our study provides new insights into factors associated with exceptional cognitive ageing and suggests that established late-life dementia risk factors may contribute to, but do not fully explain, why some individuals maintain exceptionally high cognitive function into older age.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Watson, P., Ebrahimi, O., Gallacher, J. E. J., & Bauermeister, S. (2026). Cognition in Whitehall II 'SuperAgers': An Analysis of Dementia Risk Factors. medRxiv (preprint). https://doi.org/10.1101/2025.08.12.25333490

Vancouver

Watson P, Ebrahimi O, Gallacher JEJ, Bauermeister S. Cognition in Whitehall II 'SuperAgers': An Analysis of Dementia Risk Factors. medRxiv (preprint). 2026. doi:10.1101/2025.08.12.25333490.

BibTeX

@article{watson2026-a6a005ff,
  author  = {Watson, P. and Ebrahimi, O. and Gallacher, J. E. J. and Bauermeister, S.},
  title   = {{Cognition in Whitehall II 'SuperAgers': An Analysis of Dementia Risk Factors}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.1101/2025.08.12.25333490},
  url     = {https://doi.org/10.1101/2025.08.12.25333490}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that absence of hypertension, lower depressive symptoms, higher fruit and vegetable intake, and greater social activity were modestly associated with being a SuperAger. These factors do not fully explain exceptional cognitive ageing, and the study does not show that they prevent or cure Alzheimer's disease.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 2 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 29 of the 94 points it could be judged on, which is 31 of 100. Raw total 31 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 31 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 31 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design and randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 29 of the 94 points we could judge it on, which is 31 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 3,513 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Sarah Bauermeister: h-index 18 (OpenAlex, whole career)
Institution's track record 2 / 3 University of Oxford: institution h-index 2,205 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 29 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 29 of the 94 points we could judge it on is 31 out of 100.
Total 31 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Prevention and risk

Also tagged “prevalence”

1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →